Hamid Akbari Javar
Overview
Explore the profile of Hamid Akbari Javar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahdian S, Mahmoudi-Aznaveh A, Mousavi S, Larijani B, Azizi Z, Javar H
Discov Oncol
. 2025 Feb;
16(1):222.
PMID: 39982607
Pancreatic cancer ranks as the fourth most common cause of cancer-related fatalities globally, with a notably low 5-year relative survival rate. We need to immediately develop fast, dependable, and noninvasive...
2.
Khosravi M, Jasemi S, Hayati P, Javar H, Izadi S, Izadi Z
Comput Biol Med
. 2024 Nov;
183:109261.
PMID: 39488054
Gastric cancer represents a significant global health challenge with elevated incidence and mortality rates, highlighting the need for advancements in diagnostic and therapeutic strategies. This review paper addresses the critical...
3.
Hoseinsalari A, Atapour-Mashhad H, Asili J, Tayarani-Najaran Z, Mohtashami L, Khanavi M, et al.
Curr Pharm Des
. 2024 Aug;
30(40):3213-3232.
PMID: 39177141
Purpose: This study aimed to prepare, characterize, and and evaluate a novel nanostructured lipid carriers (NLCs) formulation containing two fractions of L. (licorice) extract for the treatment of hyperpigmentation. Methods:...
4.
Abdollahi A, Aghayan H, Mousivand Z, Motasadizadeh H, Maghsoudian S, Abdorashidi M, et al.
Stem Cell Res Ther
. 2024 Aug;
15(1):262.
PMID: 39148112
Background: Mesenchymal stem cells (MSCs)-based treatment strategy has shown promise in bolstering the healing process of chronic wounds in diabetic patients, who are at risk of amputation and mortality. To...
5.
Zohri M, Arefian E, Azizi Z, Javar H, Shadboorestan A, Fatahi Y, et al.
Int J Biol Macromol
. 2024 Jul;
277(Pt 1):133995.
PMID: 39038571
This study investigated the efficacy of using chitosan/alginate nanoparticles loaded with recombinant human bone morphogenetic-2 (rhBMP-2) and SMAD4 encoding plasmid to enhance the chondrogenesis of human bone marrow mesenchymal stem...
6.
Bayrami S, Chamani M, Jamalimoghadamsiahkali S, SeyedAlinaghi S, Shirmard L, Bayrami S, et al.
J Pharm Sci
. 2024 Mar;
113(8):2552-2559.
PMID: 38508339
Purpose: In the present study, biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles (NPs) containing insulin were loaded in sodium alginate/jeffamine (ALG/jeff) hydrogel for prolonged delivery of insulin. The main aim of this...
7.
Razavi M, Ebrahimnejad P, Javar H, Weppelmann T, Akbari J, Amoli F, et al.
Biomater Adv
. 2023 Oct;
154:213648.
PMID: 37812983
In this study, a novel dual-drug carrier for the co-administration of an anti-inflammatory and antibiotic agent consisting of core-shell nanofibers for the treatment of cornea alkali burns was designed. The...
8.
Amini A, Shekari F, Kashani S, Eslami N, Nazari A, Tofigh N, et al.
Exp Neurol
. 2023 Jun;
367:114467.
PMID: 37302747
Objective: Traumatic brain injury (TBI) is a major risk factor for disabilities globally with no effective treatment thus far. Recently, homogenous population of clonal mesenchymal stem cells (cMSC) and their...
9.
Hasani M, Jafari S, Javar H, Abdollahi H, Rashidzadeh H
ACS Appl Bio Mater
. 2023 Mar;
6(3):1019-1031.
PMID: 36862384
Although chemotherapy is regarded as an essential option in cancer treatment, it is still far from being perfect. Inadequate tumor drug concentration and systemic toxicity along with broad biodistribution have...
10.
Naeimifar A, Ahmad Nasrollahi S, Samadi A, Aryanian Z, Javar H, Rouini M, et al.
J Dermatolog Treat
. 2022 Aug;
33(8):3160-3164.
PMID: 35943737
Background: Ruxolitinib is a JAK1/2 inhibitor, which inhibits the signal transduction of interferon-gamma, a cytokine implicated in the pathogenesis of atopic dermatitis (AD). In this before-after single group phase IIA...